Burberry Slumps, GSK Strikes $2bn Deal | CityCast AM – Wed 14 May 2025

London markets opened lower Wednesday as investors reacted to Burberry’s sharp swing into loss and cautious trading in global equities. Meanwhile, GSK secured a $2bn deal to expand its liver disease treatment pipeline, and Imperial Brands posted steady profits despite falling revenue.We also cover Persimmon’s £100m broadband divestment, Compass Group’s slowing growth, and early signs of recovery at Marshalls. Plus: updates from Wall Street, where Nvidia and Boeing climbed on trade and AI optimism, while UnitedHealth plunged on CEO news.Start your day sharp with CityCast AM—your five-minute financial news briefing.⏱️ Timestamps:00:00 – Intro & FTSE open: Down 20 points00:20 – Burberry reports £66m loss, warns on global tariffs00:55 – GSK signs $2bn liver disease deal with Boston Pharmaceuticals01:35 – Imperial Brands: Revenue down, profit up, guidance steady02:15 – Persimmon sells FibreNest to BUUK for £100m02:45 – Marshalls: Revenue rises, landscaping decline slows03:10 – Compass Group: Shares fall on slower organic growth03:45 – Asia markets: Nikkei down, Hang Seng gains 2%04:00 – Wall Street recap: Nasdaq +1.6%, Dow slips• UnitedHealth -17.79%• Boeing +2.46%• Nvidia +5.63% on Saudi chip deal• Microsoft slightly down on job cuts05:20 – Wrap-up: Back at lunch with more market updates